204 related articles for article (PubMed ID: 18956234)
1. Spectrofluorimetric determination of famotidine in pharmaceutical preparations and biological fluids. Application to stability studies.
Walash MI; el-Brashy A; el-Enany N; Kamel ME
J Fluoresc; 2009 Mar; 19(2):333-44. PubMed ID: 18956234
[TBL] [Abstract][Full Text] [Related]
2. Spectrofluorimetric Determination of Famotidine in Pharmaceutical Preparations and Biological Fluids through Ternary Complex Formation with Some Lanthanide Ions: Application to Stability Studies.
Walash MI; El-Brashy A; El-Enany N; Wahba ME
Int J Biomed Sci; 2009 Jun; 5(2):158-68. PubMed ID: 23675130
[TBL] [Abstract][Full Text] [Related]
3. Spectrofluorimetric analysis of famotidine in pharmaceutical preparations and biological fluids by derivatization with benzoin.
Alamgir M; Khuhawar MY; Memon SQ; Hayat A; Zounr RA
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 134():449-52. PubMed ID: 25033237
[TBL] [Abstract][Full Text] [Related]
4. Validated sensitive spectrofluorimetric method for determination of antihistaminic drug azelastine HCl in pure form and in pharmaceutical dosage forms: application to stability study.
El-Masry AA; Hammouda ME; El-Wasseef DR; El-Ashry SM
Luminescence; 2017 Mar; 32(2):177-181. PubMed ID: 27279096
[TBL] [Abstract][Full Text] [Related]
5. Spectrofluorimetric determination of oxamniquine in dosage forms and spiked human plasma through derivatization with 1-dimethylaminonaphthalene-5-sulphonyl chloride.
El-Enany N; Belal F; Rizk M
J Fluoresc; 2008 Mar; 18(2):349-55. PubMed ID: 18058206
[TBL] [Abstract][Full Text] [Related]
6. Sensitive spectrofluorimetric determination of tizanidine in pharmaceutical preparations, human plasma and urine through derivatization with dansyl chloride.
Ulu ST
Luminescence; 2012; 27(5):426-30. PubMed ID: 23044773
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of highly Sensitive Stability Indicating Spectrofluorimetric Method for Determination of Amlodipine in Pharmaceutical Preparations and Human Plasma.
Mohamed AI; Omar MA; Hammad MA; Mohamed AA
J Fluoresc; 2016 Nov; 26(6):2141-2149. PubMed ID: 27566613
[TBL] [Abstract][Full Text] [Related]
8. Spectrofluorimetric determination of streptomycin in dosage forms and in spiked plasma using 9,10-phenanthraquinone.
Belal F; El-Ashry SM; El Kerdawy MM; El Wasseef DR
J Pharm Biomed Anal; 2001 Oct; 26(3):435-41. PubMed ID: 11489389
[TBL] [Abstract][Full Text] [Related]
9. Selective Spectrofluorimetric Method with Enhanced Sensitivity for Determination of Silodosine in Dosage Form and Human Plasma. Application to Stability Studies and Content Uniformity Testing.
Omar MA; Mohamed AI; Derayea SM; Hammad MA; Mohamed AA
J Fluoresc; 2017 Mar; 27(2):473-482. PubMed ID: 27864702
[TBL] [Abstract][Full Text] [Related]
10. Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column.
Helali N; Monser L
J Sep Sci; 2008 Feb; 31(2):276-82. PubMed ID: 18172920
[TBL] [Abstract][Full Text] [Related]
11. Spectrofluorimetric determination of tobramycin in human serum and pharmaceutical preparations by derivatization with fluorescamine.
Tekkeli SE; Önal A; Sağırlı AO
Luminescence; 2014 Feb; 29(1):87-91. PubMed ID: 23520194
[TBL] [Abstract][Full Text] [Related]
12. Spectrofluorimetric determination of oseltamivir phosphate through derivatization with o-phthalaldehyde. Application to pharmaceutical preparations with a preliminary study on spiked plasma samples.
Walash MI; Belal F; El-Enany N; El-Maghrabey MH
Luminescence; 2012; 27(6):511-8. PubMed ID: 22362604
[TBL] [Abstract][Full Text] [Related]
13. Use of mixed anhydrides for the determination of terfenadine in dosage forms and spiked human plasma.
Al-Majed AA; Al-Zehouri J; Belal F
J Pharm Biomed Anal; 2000 Aug; 23(2-3):281-9. PubMed ID: 10933521
[TBL] [Abstract][Full Text] [Related]
14. Stability-Indicating Spectrofluorimetric Methods for the Determination of Metolazone and Xipamide in Their Tablets. Application to Content Uniformity Testing.
Walash MI; El-Enany N; Eid MI; Fathy ME
J Fluoresc; 2014 Mar; 24(2):363-76. PubMed ID: 24091803
[TBL] [Abstract][Full Text] [Related]
15. An eco-friendly stability-indicating spectrofluorimetric method for the determination of two anticancer stereoisomer drugs in their pharmaceutical preparations following micellar enhancement: Application to kinetic degradation studies.
El-Kimary EI; El-Yazbi AF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jun; 163():145-53. PubMed ID: 27045788
[TBL] [Abstract][Full Text] [Related]
16. Conventional and first derivative synchronous fluorometric determination of ethamsylate in pharmaceutical preparations and biological fluids. Application to stability studies.
Belal F; El-Brashy A; El-Enany N; Tolba M
J Fluoresc; 2011 Jul; 21(4):1371-84. PubMed ID: 21347837
[TBL] [Abstract][Full Text] [Related]
17. Spectrofluorimetric determination of sertraline in dosage forms and human plasma through derivatization with 9-fluorenylmethyl chloroformate.
El-Enany NM; Abdelal A; Belal F
Chem Cent J; 2011 Oct; 5():56. PubMed ID: 21978386
[TBL] [Abstract][Full Text] [Related]
18. Validated spectrofluorimetric method for determination of two phosphodiesterase inhibitors tadalafil and vardenafil in pharmaceutical preparations and spiked human plasma.
Abu El-Enin MA; Al-Ghaffar Hammouda Mel-S; El-Sherbiny DT; El-Wasseef DR; El-Ashry SM
Luminescence; 2016 Feb; 31(1):173-8. PubMed ID: 26019060
[TBL] [Abstract][Full Text] [Related]
19. Spectrofluorometric determination of labetolol in pharmaceutical preparations and spiked human urine through the formation of coumarin derivative.
Belal F; Al-Shaboury S; Al-Tamrah AS
J Pharm Biomed Anal; 2002 Nov; 30(4):1191-6. PubMed ID: 12408909
[TBL] [Abstract][Full Text] [Related]
20. Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).
Walsh M; Belal F; El-Enany N; Elmansi H
J Fluoresc; 2011 Jan; 21(1):105-12. PubMed ID: 20593227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
